FCM
NKTR icon

Frontier Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Frontier Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,388
Closed -$1.5M – 274
2021
Q4 		$1.5M Buy
7,388
+1,135
+18% +$246K 0.01% 270
2021
Q3 		$1.69M Sell
6,253
-1,538
-20% -$370K 0.01% 273
2021
Q2 		$2.01M Sell
7,791
-21,937
-74% -$6.07M 0.01% 278
2021
Q1 		$8.92M Buy
29,728
+22,873
+334% +$7.12M 0.07% 230
2020
Q4 		$1.75M Sell
6,855
-48,496
-88% -$12.5M 0.01% 279
2020
Q3 		$13.8M Sell
55,351
-4,394
-7% -$1.38M 0.12% 190
2020
Q2 		$20.8M Sell
59,745
-15,335
-20% -$4.79M 0.18% 163
2020
Q1 		$20.1M Buy
75,080
+30,653
+69% +$9.48M 0.23% 144
2019
Q4 		$14.4M Sell
44,427
-8,500
-16% -$2.46M 0.11% 201
2019
Q3 		$14.5M Sell
52,927
-4,615
-8% -$1.69M 0.11% 199
2019
Q2 		$30.7M Buy
57,542
+2,319
+4% +$1.16M 0.23% 147
2019
Q1 		$27.8M Buy
55,223
+2,197
+4% +$1.3M 0.2% 160
2018
Q4 		$26.1M Sell
53,026
-33,526
-39% -$20.2M 0.21% 148
2018
Q3 		$79.1M Buy
86,552
+13,726
+19% +$11.7M 0.51% 63
2018
Q2 		$53.3M Buy
72,826
+27,755
+62% +$32M 0.38% 105
2018
Q1 		$71.8M Buy
+45,071
New +$58.1M 0.52% 62

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Frontier Capital Management's NKTR Position: Q1 2022 in Review

Frontier Capital Management sold out of Nektar Therapeutics (NKTR) in Q1 2022, closing a stake of 7,388 shares — an estimated $1.5M sold.

Frontier Capital Management first reported a position in NKTR in Q1 2018 and held it in 16 quarters. The position peaked at $79.1M in Q3 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q1 2022.

  • Frontier Capital Management reported no remaining Nektar Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Frontier Capital Management sold 7,388 Nektar Therapeutics shares in Q1 2022, an estimated $1.5M.
  • Frontier Capital Management first reported a position in Nektar Therapeutics in Q1 2018 and held it in 16 quarters.
  • Frontier Capital Management's Nektar Therapeutics position peaked at $79.1M in Q3 2018.
  • 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2022.

Based on Frontier Capital Management's 13F filing for Q1 2022, filed 14 Apr 2022.